Basil Onugu

Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation.

Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation.

Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation.